oncology drug development

Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of people with cancer who experience hearing loss as a result of chemotherapy. It is fiercely devoted to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy, aiming to help protect the futures of cancer survivors by preventing hearing loss. The company markets PEDMARK® and works through education and collaboration with the oncology community to make ototoxicity prevention part of the treatment plan.

Read more

biotechnologycommercialization of therapies